Graft rejection, Pophylaxis of acute renal transplant rejection, Pophylaxis of cardiac transplant rejection., It is used with other medicines to prevent your body from rejecting an organ (such as a kidney, heart or liver) after a transplant.
|Country of origin||
Teratogenic in animals, avoid inhalation or direct skin contact. Monitor patients for lymphoproliferative disorders; advise patient to limit exposure to sunlight/UV light. Active peptic ulcer disease. Severe renal impairment. Mycophenolate mofetil and mycophenolate sodium are not interchangeable. Monitor for neutropenia., Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and Neonates.
Diarrhoea, vomiting, GI haemorrhage and perforation; leucopenia; asthenia, pain, headache, anaemia, thrombocytopenia, renal tubular necrosis, haematuria, BP changes, hyperglycaemia, disturbances of electrolytes and blood lipids, peripheral oedema, dyspnoea, cough, acne, hepatitis. Angioedema, anaphylaxis, fatal pulmonary fibrosis.
Pregnancy, lactation. Rare hereditary deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), including Kelley-Seegmiller.